The Billerica, Mass.-based company’s Omnipod Dash system wirelessly connects Insulet’s Personal Diabetes Manager with a tubeless, waterproof insulin pump. The PDM calculates how much insulin should be administered using blood glucose readings from the Contour Next One blood glucose meter.
Altogether, the system connects via Bluetooth to mobile apps, which provide users and caregivers with access to their insulin therapy data.
The FDA cleared Insulet’s Omnipod Dash system in June. The company expects to fully launch the product in early 2019 – it’s currently undergoing a limited market release.
Insulet also reported this week that it received the Diabetes Technology Society’s Cybersecurity Standard for Connected Diabetes Devices Security certification for the Omnipod Dash system.
The company noted that it is the only insulin company to have won both certifications.
“This is part of a large-scale organizational commitment to ensure the highest-level of cyber security of our Omnipod DASH System and to provide information security our Podders can trust,” EVP & CTO Dr. Aiman Abdel-Malek said in prepared remarks.
“We are committed to remaining at the forefront of best-in-class standards to secure patients’ safety and privacy. Our compliance with these internationally recognized standards sets us apart from others in the global insulin pump market and provides our users with further peace of mind that they can rely on a highly safe and secure product to manage their diabetes,” Abdel-Malek added.